Akar, S. Et Al. 2022. beta-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene. MOLECULAR BIOLOGY REPORTS , vol.49, no.8 , 7409-7415.

Akar, S., ALTUNTAŞ, H., & HAMURCU, Z., (2022). beta-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene. MOLECULAR BIOLOGY REPORTS , vol.49, no.8, 7409-7415.

Akar, Sakine, HAMİYET ALTUNTAŞ, And ZÜHAL HAMURCU. "beta-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene," MOLECULAR BIOLOGY REPORTS , vol.49, no.8, 7409-7415, 2022

Akar, Sakine Et Al. "beta-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene." MOLECULAR BIOLOGY REPORTS , vol.49, no.8, pp.7409-7415, 2022

Akar, S. ALTUNTAŞ, H. And HAMURCU, Z. (2022) . "beta-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene." MOLECULAR BIOLOGY REPORTS , vol.49, no.8, pp.7409-7415.

@article{article, author={Sakine Akar Et Al. }, title={beta-Escin reduces cancer progression in aggressive MDA-MB-231 cells by inhibiting glutamine metabolism through downregulation of c-myc oncogene}, journal={MOLECULAR BIOLOGY REPORTS}, year=2022, pages={7409-7415} }